Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal

Home page

NA2 - Virtual college for improvement of animal infectious disease studies

Rabbit EOPS
© Inra, Dominique Licois
The objectives of NA2 are: training of project-internal and external scientists and technicians in various aspects of animal experimentation, including biosafety aspects, ethics and best practices, harmonisation and standardization of procedures, coordination of animal studies for validation and standardization studies performed under this project and facilitate ethical reflection and knowledge exchange on ethical, social and legal issues.

Background

Within Europe there are various sites where animal infectious diseases are studied. The focus of these facilities varies from highly specialized, e.g. the fish facilities of VESO and high containment facilities for animal

diseases, to more general facilities. Working with animals in specific conditions,especially BL3 containment conditionsrepresents a practical compromise between the normal behavior of the animal and its welfare and

the need to contain the infectious agent that is being studied.

The members of the consortium represent the majority, if not all, of farm animal BL3 facilities across Europe. There is a large variation in the designs of these buildings, and also the work undertaken in them varies in detail. The comprehensive know-how held by the members of the consortium provides the capability for developing the competences of other members of the consortium and new users, and for transfer of technology.

Development of new technologies for diagnostics of infectious animal diseases and collection of material for validation and standardization require well-defined studies, including experimental animal studies.

Coordination and standardization of such studies by the consortium will optimize the output and increase scientific knowledge while minimizing the use of animals. In addition the consortium will develop new practices

and protocols and exchange existing ones between the members of the consortium, which will contribute to the best comparable approach of animal studies in the different countries.

Other complex issues are biosafety, biosecurity and animal welfare. Working with animals in BL3/BL3+ containment facilities makes heavy demands on the knowledge of bio-security, experimental models of infectious diseases, and the impact on animal welfare caused by these diseases. Animal welfare is of great concern to the public as well as for animal disease researchers. Although implementation of animal experiments is regulated by national legislation, the conditions for carrying out experiments vary considerably from country to country. Therefore, the consortium will joint efforts to improve the standardization of the conditions for animal experiments.

Approach

For the improvement of animal infectious studies in Europe, NA2 will focus on:

  • Best practices and procedure exchange
  • Biosecurity regulations
  • Standardization of diagnostics and validation
  • Coordination of experimental animal studies required for novel technologies
  • Animal welfare and ethical engagement
  • Legal and social aspects analysis
  • Training and professional development of internal and external researchers, PhD students, and technicians
  • Together, this network of facilities and activities will provide a virtual animal disease research facility where
  • practical approaches to animal disease questions, procedures and protocols and animal welfare issues in experimental settings become highly comparable.

NA2 Leader

  • University of Nottingham

Involved partners

  • All the partners